Year: 2017
Type: review
Abstract: Diabetes is a significant health problem worldwide, and its association with cardiovascular disease (CVD) was reported in several studies. Hyperglycemia and insulin resistance seen in diabetes and prediabetes lead to an increase in reactive oxygen species, which triggers intracellular molecular signaling. The resulting prothrombotic state and increase in inflammatory mediators expedite atherosclerotic changes and the development of macrovascular complications. Individuals with diabetes or prediabetes have a higher risk of developing myocardial infarction, stroke, and peripheral artery disease. However, no significant difference in cardiovascular morbidity has been observed with tight glycemic control despite a reduction in some CVD outcomes, and the risk of adverse outcomes such as hypoglycemia was increased. Recently, some GLP-1 receptor agonists and SGLT-2 inhibitors have been shown to reduce cardiovascular events and mortality. In this review we give an overview of the risk and pathogenesis of cardiovascular disease among diabetic and prediabetic patients, as well as the implication of recent changes in diabetes management.
Source: BioMed Research International
DOI: 10.1155/2017/7839101
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: macrovascular complications, diabetes mellitus, prediabetes, cardiovascular disease, hyperglycemia, insulin resistance, reactive oxygen species, atherosclerosis, hypercoagulability, inflammation, myocardial infarction, stroke, peripheral arterial disease, glycemic control, hypoglycemia, GLP-1 receptor agonists, SGLT2 inhibitors, diabetes management
Open Access status: hybrid
Estimated APC paid: $2,680
OpenAlex ID: W2767450049
